Demand for Class B properties is gaining steam as Class A office space, including Two Labs' new location at Dublin's Bridge ...
Boehringer Ingelheim today announced the start of a Phase IIa clinical trial evaluating BI 765423, a novel monoclonal antibody targeting interleukin-11 (IL-11), in patients with idiopathic pulmonary ...
Here are the 40 Under 40 winners this year and an outstanding alumnus who is entering the Hall of Fame.